UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 174 filers reported holding UNIQURE NV in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $506,697 | +152.1% | 22,351 | +130.8% | 0.00% | – |
| Q4 2021 | $201,000 | -61.6% | 9,684 | -40.8% | 0.00% | -100.0% |
| Q3 2021 | $523,000 | +49.9% | 16,348 | +44.1% | 0.00% | 0.0% |
| Q2 2021 | $349,000 | -18.6% | 11,343 | -11.0% | 0.00% | 0.0% |
| Q1 2021 | $429,000 | +35.8% | 12,745 | +45.8% | 0.00% | 0.0% |
| Q4 2020 | $316,000 | – | 8,739 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 955,424 | $32,188,000 | 5.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 282,034 | $9,490,000 | 2.51% |
| Nantahala Capital Management | 1,672,891 | $56,360,000 | 1.65% |
| Henry James International Management Inc. | 149,053 | $5,022,000 | 1.51% |
| Nantahala Capital Management | 1,500,000 | $50,535,000 | 1.48% |
| Voss Capital, LLC | 90,000 | $3,032,000 | 1.26% |
| P.A.W. CAPITAL CORP | 30,000 | $1,011,000 | 0.89% |
| Sofinnova Investments, Inc. | 427,122 | $14,390,000 | 0.86% |
| Caption Management, LLC | 1,078,800 | $36,343,000 | 0.78% |
| Sivik Global Healthcare LLC | 61,768 | $2,081,000 | 0.76% |